Related Experiment Videos
Hepatitis C and hepatocellular carcinoma
1Department of Internal Medicine, St. Louis University School of Medicine, MO 63104, USA.
Hepatology (Baltimore, Md.)
|September 26, 1997
Summary
Hepatitis C virus (HCV) infection significantly increases the risk of hepatocellular carcinoma (HCC), often developing decades after initial infection. Developing effective screening and prevention strategies for HCV-related HCC is crucial due to disappointing treatment outcomes.
Area of Science:
- Hepatology and Viral Oncology
- Gastroenterology and Carcinogenesis
Background:
- Hepatitis C virus (HCV) is a primary risk factor for hepatocellular carcinoma (HCC).
- HCV infection typically leads to HCC through cirrhosis, with a long incubation period of 20-30 years.
- Co-factors like HCV genotype 1b, alcohol, and hepatitis B virus (HBV) may increase HCC risk.
Framework:
- The progression from chronic hepatitis C to cirrhosis occurs in approximately 20% of cases over a decade.
- Annual HCC development rates in patients with cirrhosis range from 1% to 4%.
- An estimated 1.9% to 6.7% of chronic HCV patients may develop HCC within two decades.
Implementation:
- Current screening tests for early HCC show disappointing treatment results.
- Research is ongoing to understand the direct carcinogenic effects of HCV.
- Focus is needed on identifying and managing additional risk factors.
Implications:
- Cost-effective screening and prevention methods for HCV-related HCC are urgently needed.
- Early detection and intervention strategies require further development.
- Understanding the long-term oncogenesis of HCV is critical for public health.